Stat3 activation in prostatic carcinomas

Prostate

Volumn 51, Issue 4, 2002, Pages 241-246

  Dhir, Rajiv ^a   Ni, Zuyao ^a   Lou, Wei ^a   DeMiguel, Fernando ^a   Grandis, Jennifer Rubin ^a   Gao, Allen C ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

IL 6; Prostate; Stat3

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; STAT3 PROTEIN;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN PHOSPHORYLATION;

CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0036604124     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10079     Document Type: Article

References (18)

1. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
2. STATs and gene regulation
3. Stat-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients
4. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts
5. Constitutive activation of stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
6. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein
7. Jak-STAT signaling induced by the v-abl oncogene
8. Stat3 as an oncogene
9. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway
10. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells
11. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
12. Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia
13. Interleukin-6: A candidate mediator of human prostate cancer morbidity
14. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant, and malignant prostate tissue
15. Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma
16. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
17. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells
18. Increased expression of the interleukin-11 receptor and evidence of Stat3 activation in prostate carcinoma